Skip to Content
You are currently on the new version of our website. Access the old version .

165 Results Found

  • Article
  • Open Access
42 Citations
16,085 Views
10 Pages

Non-Alcoholic Fatty Liver Disease in Patients with Type 2 Diabetes: Evaluation of Hepatic Fibrosis and Steatosis Using Fibroscan

  • Tran Thi Khanh Tuong,
  • Dang Khoa Tran,
  • Pham Quang Thien Phu,
  • Tong Nguyen Diem Hong and ,
  • Thien Chu Dinh and
  • Dinh Toi Chu
  • + 1 author+ 0 author

Patients with type 2 diabetes mellitus (T2DM) are at increased risk of non-alcoholic fatty liver disease (NAFLD) and might eventually progress to advanced fibrosis, cirrhosis and hepatocellular carcinoma (HCC). Recommendations on whether to screen fo...

(This article belongs to the Special Issue Diagnosing NAFLD: Which Tool, Where, When and Why to Use It)
  • Review
  • Open Access
127 Citations
16,262 Views
11 Pages

Diagnostic Accuracy of FibroScan and Factors Affecting Measurements

  • Satoshi Oeda,
  • Kenichi Tanaka,
  • Ayaka Oshima,
  • Yasue Matsumoto and ,
  • Eisaburo Sueoka and
  • Hirokazu Takahashi
  • + 1 author+ 0 author

12 November 2020

Evaluating liver steatosis and fibrosis is important for patients with non-alcoholic fatty liver disease. Although liver biopsy and pathological assessment is the gold standard for these conditions, this technique has several disadvantages. The evalu...

(This article belongs to the Special Issue Fatty Liver Disease: Diagnostic, Predictive and Prognostic Markers)
  • Article
  • Open Access
7 Citations
1,971 Views
16 Pages

Liver Fibrosis Is Positively and Independently Associated with Leptin Circulating Levels in Individuals That Are Overweight and Obese: A FibroScan-Based Cross-Sectional Study

  • Nicole Cerabino,
  • Martina Di Chito,
  • Davide Guido,
  • Vincenza Di Stasi and ,
  • Caterina Bonfiglio,
  • Giuseppe Lisco,
  • Endrit Shahini,
  • Marianna Zappimbulso,
  • Raffaele Cozzolongo and
  • Giovanni De Pergola
  • + 13 authors+ 8 authors

1 June 2025

Background: Metabolic dysfunction-associated steatotic liver disease (MASLD) is strongly correlated with the severity of obesity, and the extent of liver fibrosis is associated with a higher risk of liver-related complications, cardiovascular events,...

(This article belongs to the Section Nutrition and Obesity)
  • Article
  • Open Access
1,145 Views
15 Pages

Chronotype and FibroScan-Derived Liver Markers in Adults with Obesity: Preliminary Evidence from a Cross-Sectional Study

  • Nicole Cerabino,
  • Davide Guido,
  • Leonilde Bonfrate,
  • Endrit Shahini and ,
  • Vincenza Di Stasi,
  • Martina Di Chito,
  • Maria Noemy Pastore,
  • Sergio Coletta,
  • Anna Ancona and
  • Giovanni De Pergola
  • + 6 authors+ 1 author

16 July 2026

Background/Objectives: Chronotype describes individual preferences regarding the timing of sleep, food intake, and other daily activities and is commonly evaluated using the Morningness–Eveningness Questionnaire (MEQ). Individuals with a mornin...

(This article belongs to the Section Nutrition and Obesity)
  • Article
  • Open Access
11 Citations
3,639 Views
12 Pages

The Efficacy of Anthropometric Indicators in Predicting Non-Alcoholic Fatty Liver Disease Using FibroScan® CAP Values among the Taiwanese Population

  • Meng-Szu Lee,
  • Eva Belingon Felipe-Dimog,
  • Jeng-Fu Yang,
  • Yi-Yu Chen and ,
  • Kuan-Ta Wu,
  • Hsiang-Ju Kuo,
  • Tzu-Chun Lin,
  • Chao-Ling Wang,
  • Meng-Hsuan Hsieh and
  • Chia-Yen Dai
  • + 9 authors+ 4 authors

12 September 2023

The controlled attenuation parameter (CAP) measurement obtained from FibroScan® is a low-risk method of assessing fatty liver. This study investigated the association between the FibroScan® CAP values and nine anthropometric indicators, inclu...

(This article belongs to the Section Molecular and Translational Medicine)
  • Article
  • Open Access
2 Citations
3,168 Views
12 Pages

Comparison Between Transient Elastography and Point Shear Wave Elastography in the Assessment of Liver Fibrosis According to the Grade of Liver Steatosis

  • Giuseppe Losurdo,
  • Antonino Castellaneta,
  • Claudia Di Nuccio,
  • Paola Dell’Aquila and ,
  • Ilaria Ditonno,
  • Domenico Novielli,
  • Antonio Continisio,
  • Margherita De Bellis,
  • Alfredo Di Leo and
  • Michele Barone
  • + 6 authors+ 1 author

1 August 2025

Background: Transient elastography (TE), using Fibroscan® and point shear wave elastography (pSWE), are two techniques used to estimate liver fibrosis. The aim of our study was to compare, for the first time, these two techniques in Metabolic Dys...

(This article belongs to the Special Issue Clinical Advances in Metabolic Dysfunction-Associated Steatotic Liver Disease)
  • Article
  • Open Access
6 Citations
3,495 Views
22 Pages

FibroScan® versus Biochemical Scores: A Study of Liver Fibrosis in HIV with HBV Co-Infection

  • Giorgiana Nicoleta Lungu,
  • Gheorghe Iulian Diaconescu,
  • Florentina Dumitrescu,
  • Anca Oana Docea and ,
  • Radu Mitrut,
  • Lucian Giubelan,
  • Ovidiu Zlatian and
  • Paul Mitrut
  • + 3 authors+ 0 author

The study aimed to determine liver fibrosis in human immunodeficiency virus (HIV) positive individuals using transient elastography (FibroScan®), Fibrosis-4 (FIB-4) score, and aspartate aminotransferase (AST) to Platelet Ratio Index (APRI) in the...

(This article belongs to the Special Issue Control and Elimination of Viral Hepatitis)
  • Article
  • Open Access
2 Citations
4,144 Views
16 Pages

Switching to Bictegravir/Emtricitabine/Tenofovir Alafenamide Fumarate Regimen and Its Effect on Liver Steatosis Assessed by Fibroscan

  • Marcello Trizzino,
  • Roberta Gaudiano,
  • Dalila Mimì Arena,
  • Luca Pipitò and ,
  • Claudia Gioè and
  • Antonio Cascio
  • + 1 author+ 0 author

19 March 2025

Background: Antiretroviral therapy has transformed HIV infection from a fatal disease to a chronic and manageable condition, but increasing health issues beyond acquired immunodeficiency syndrome, such as metabolic, liver, and cardiovascular diseases...

(This article belongs to the Section Human Virology and Viral Diseases)
  • Brief Report
  • Open Access
16 Citations
10,942 Views
10 Pages

Comparison of Transient Elastography and Point Shear Wave Elastography for Analysis of Liver Stiffness: A Prospective Study

  • Giuseppe Losurdo,
  • Ilaria Ditonno,
  • Domenico Novielli,
  • Francesca Celiberto and ,
  • Andrea Iannone,
  • Antonino Castellaneta,
  • Paola Dell’Aquila,
  • Nunzio Ranaldo,
  • Maria Rendina and
  • Alfredo Di Leo
  • + 7 authors+ 2 authors

Liver stiffness measurement (LSM) by Fibroscan is the most used non-invasive method to assess liver fibrosis. Recently, point-shear wave elastography (pSWE) has been introduced as a simple alternative non-invasive test. Therefore, we aimed to compare...

(This article belongs to the Special Issue Advances in the Prevention, Diagnosis, and Management of Liver Diseases)
  • Article
  • Open Access
11 Citations
5,329 Views
9 Pages

26 May 2023

Background and Objectives: Methotrexate (MTX) is routinely prescribed for rheumatoid arthritis (RA) patients, but high cumulative doses may lead to hepatic fibrosis. Additionally, a high proportion of RA patients suffer from metabolic syndrome, which...

(This article belongs to the Section Hematology and Immunology)
  • Article
  • Open Access
2 Citations
3,726 Views
15 Pages

Exploring the Potential Performance of Fibroscan for Predicting and Evaluating Metabolic Syndrome using a Feature Selected Strategy of Machine Learning

  • Kuan-Lin Chiu,
  • Yu-Da Chen,
  • Sen-Te Wang,
  • Tzu-Hao Chang and ,
  • Jenny L Wu,
  • Chun-Ming Shih and
  • Cheng-Sheng Yu
  • + 2 authors+ 0 author

Metabolic syndrome (MetS) includes several conditions that can increase an individual’s predisposition to high-risk cardiovascular events, morbidity, and mortality. Non-alcoholic fatty liver disease (NAFLD) is a predominant cause of cirrhosis,...

(This article belongs to the Special Issue Metabolic Profiles and Fibrosis of Nonalcoholic Fatty Liver Disease)
  • Article
  • Open Access
15 Citations
3,020 Views
13 Pages

24 October 2019

Background: There is a medical need for an easy, fast, and non-invasive method for metabolic syndrome (MetS) screening. This study aimed to assess the ability of FibroScan to detect MetS, in participants who underwent a self-paid health examination....

(This article belongs to the Section Epidemiology & Public Health)
  • Review
  • Open Access
41 Citations
9,280 Views
23 Pages

Non-Invasive Measurement of Hepatic Fibrosis by Transient Elastography: A Narrative Review

  • Luca Rinaldi,
  • Chiara Giorgione,
  • Andrea Mormone,
  • Francesca Esposito and ,
  • Michele Rinaldi,
  • Massimiliano Berretta,
  • Raffaele Marfella and
  • Ciro Romano
  • + 3 authors+ 0 author

13 August 2023

Transient elastography by FibroScan® (Echosens, Paris, France) is a non-invasive method that can provide a reliable measurement of liver fibrosis through the evaluation of liver stiffness. Despite its limitations and risks, liver biopsy has thus...

(This article belongs to the Section Human Virology and Viral Diseases)
  • Article
  • Open Access
1,070 Views
14 Pages

Clinical Validation of a Deep Learning-Based 2D Ultrasound Steatosis Algorithm: Cutoff Transferability, Scanner Generalizability, and Comparison with FibroScan

  • Jennifer Tai,
  • Tse-Hwa Hsu,
  • Cheng-Jen Chen,
  • Ming-Ling Chang and ,
  • Chihung Lin,
  • Shiu-Feng Huang,
  • Le Lu,
  • Adam P. Harrison and
  • Dar-In Tai
  • + 4 authors+ 0 author

Background: Liver steatosis assessment by 2D ultrasound is widely used but remains subjective. We previously developed a deep learning (DL) algorithm for objective steatosis quantification. This study aimed to (1) establish histology-based cutoffs, (...

(This article belongs to the Section Machine Learning and Artificial Intelligence in Diagnostics)
  • Article
  • Open Access
44 Citations
9,313 Views
11 Pages

Effects of an Eight Week Very Low-Calorie Ketogenic Diet (VLCKD) on White Blood Cell and Platelet Counts in Relation to Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) in Subjects with Overweight and Obesity

  • Sara De Nucci,
  • Caterina Bonfiglio,
  • Rosanna Donvito,
  • Martina Di Chito and ,
  • Nicole Cerabino,
  • Roberta Rinaldi,
  • Annamaria Sila,
  • Endrit Shahini,
  • Vito Giannuzzi and
  • Giovanni De Pergola
  • + 11 authors+ 6 authors

21 October 2023

Obesity and metabolic dysfunction-associated steatotic liver disease (MASLD) are frequently associated conditions characterized by low-grade inflammation. Very low-calorie ketogenic diet (VLCKD) strategies are commonly used to simultaneously obtain w...

(This article belongs to the Section Nutrition and Diabetes)
  • Article
  • Open Access
43 Citations
10,956 Views
11 Pages

The Effects of Eight Weeks’ Very Low-Calorie Ketogenic Diet (VLCKD) on Liver Health in Subjects Affected by Overweight and Obesity

  • Roberta Rinaldi,
  • Sara De Nucci,
  • Fabio Castellana,
  • Martina Di Chito and ,
  • Vito Giannuzzi,
  • Endrit Shahini,
  • Roberta Zupo,
  • Luisa Lampignano,
  • Giuseppina Piazzolla and
  • Giovanni De Pergola
  • + 8 authors+ 3 authors

6 February 2023

Very low-calorie ketogenic diets (VLCKD) are widely employed in successful weight-loss strategies. Herein, we evaluated the efficacy and safety of a VLCKD on non-alcoholic fatty liver disease (NAFLD) and parameters commonly associated with this condi...

(This article belongs to the Special Issue The Role of Ketogenic Diet in Human Health and Diseases)
  • Systematic Review
  • Open Access
22 Citations
5,075 Views
20 Pages

6 November 2024

Background: Vibration-Controlled Transient Elastography (VCTE) with FibroScan is a non-invasive, reliable diagnostic tool for Metabolic-Dysfunction-Associated Steatotic Liver Disease (MASLD), enabling early detection and management to prevent severe...

(This article belongs to the Special Issue Advances in Diagnosis and Management of Gastrointestinal and Hepato-Bilio-Pancreatic Disorders)
  • Article
  • Open Access
15 Citations
2,609 Views
16 Pages

Sex Differences in MASLD After Age 50: Presentation, Diagnosis, and Clinical Implications

  • Ilaria Milani,
  • Maria Eugenia Parrotta,
  • Luca Colangeli,
  • Marianna Chinucci and ,
  • Simonetta Palleschi,
  • Barbara Rossi,
  • Paolo Sbraccia,
  • Alessandro Mantovani,
  • Frida Leonetti and
  • Danila Capoccia
  • + 6 authors+ 1 author

18 September 2025

Background: Age over 50, menopause, obesity and type 2 diabetes (T2D) are key risk factors for Metabolic dysfunction-associated steatotic liver disease (MASLD). This observational study aimed to assess sex differences in anthropometric and clinical p...

(This article belongs to the Special Issue Connections Between Diabetes Mellitus, Other Metabolic and Endocrine Dysfunctions and Cardiovascular Pathologies—Second Edition)
  • Article
  • Open Access
11 Citations
6,627 Views
10 Pages

The Replacement of Only One Portion of Starchy Carbohydrates with Green Leafy Vegetables Regresses Mid and Advanced Stages of NAFLD: Results from a Prospective Pilot Study

  • Sara De Nucci,
  • Roberta Rinaldi,
  • Martina Di Chito,
  • Rossella Donghia and ,
  • Vito Giannuzzi,
  • Endrit Shahini,
  • Raffaele Cozzolongo,
  • Pasqua Letizia Pesole,
  • Sergio Coletta and
  • Gianluigi Giannelli
  • + 6 authors+ 1 author

12 May 2023

The gold standard treatment for NAFLD is weight loss and lifestyle interventions, which require a diet enriched in fiber and reduced in sugars and saturated fats. Fibres may be advantageous for NAFLD patients since they reduce and slow the absorption...

(This article belongs to the Section Nutrition and Metabolism)
  • Review
  • Open Access
795 Views
11 Pages

Summary of Guidelines for Identifying and Risk-Stratifying Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease: A Primer for Family Physicians

  • Mitchell P. Wilson,
  • Abdel-Aziz Shaheen,
  • Victoria Leung,
  • An Tang and ,
  • Andreu F. Costa,
  • Casey Hurrell and
  • Gavin Low
  • + 2 authors+ 0 author

Multiple North American and European societies now endorse a combined serological and imaging-based clinical care pathway for non-invasive risk stratification of patients with metabolic dysfunction-associated steatotic liver disease (MASLD). A multid...

(This article belongs to the Special Issue Clinical Diagnosis and Management of Liver Diseases)
  • Article
  • Open Access
18 Citations
4,797 Views
12 Pages

Liver fibrosis is a key pathophysiology process in chronic liver disease. It is still unclear whether the impact of liver fibrosis is not fully realized in type 2 diabetes mellitus (T2D) patients with nonalcoholic fatty liver disease (NAFLD), and the...

(This article belongs to the Special Issue 10th Anniversary of Biomedicines—NAFLD: From Mechanisms to Therapeutic Approaches)
  • Article
  • Open Access
340 Views
12 Pages

Frequency of CAP-Defined Hepatic Steatosis and Its Association with Liver Fibrosis in Patients with Hepatitis Delta

  • Çiğdem Mermutluoğlu,
  • Saim Dayan,
  • Yakup Demir,
  • Ayşe Özlem Mete and
  • Mustafa Kemal Çelen

7 October 2026

Background and Aim: Hepatitis delta virus (HDV) infection is among the most aggressive forms of chronic viral hepatitis: fibrosis advances quickly, and cirrhosis, hepatocellular carcinoma (HCC) and hepatic decompensation develop more often than with...

(This article belongs to the Section Human Virology and Viral Diseases)
  • Article
  • Open Access
12 Citations
4,579 Views
12 Pages

Liver Fibrosis Regression and Associated Factors in HCV Patients Treated with Direct-Acting Antiviral Agents

  • Naim Abu-Freha,
  • Osama Abu-Kosh,
  • David Yardeni,
  • Yaffa Ashur and ,
  • Muhammad Abu-Arar,
  • Baha Yousef,
  • Shulamit Monitin,
  • Sarah Weissmann and
  • Ohad Etzion
  • + 4 authors+ 0 author

5 September 2023

There is accumulating evidence that treatment of chronic hepatitis C (HCV) leads to improvements in liver fibrosis. We aimed to investigate the improvement in fibrosis stage following treatment with direct-acting antivirals (DAAs) and factors associa...

(This article belongs to the Section Medical Research)
  • Article
  • Open Access
24 Citations
4,313 Views
11 Pages

Gut Microbiota and Non-Alcoholic Fatty Liver Disease Severity in Type 2 Diabetes Patients

  • Hui-Ju Tsai,
  • Yi-Chun Tsai,
  • Wei-Wen Hung,
  • Wei-Chun Hung and ,
  • Chen-Chia Chang and
  • Chia-Yen Dai
  • + 1 author+ 0 author

23 March 2021

Introduction: Non-alcoholic fatty liver disease (NAFLD) remains an important health issue worldwide. The increasing prevalence of NAFLD is linked to type 2 diabetes (T2D). The gut microbiota is associated with the development of NAFLD and T2D. Howeve...

  • Article
  • Open Access
18 Citations
4,653 Views
12 Pages

Role of Transient Elastography to Stage Fontan-Associated Liver Disease (FALD) in Adults with Single Ventricle Congenital Heart Disease Correction

  • Liliana Chemello,
  • Massimo Padalino,
  • Chiara Zanon,
  • Luisa Benvegnu’ and ,
  • Roberta Biffanti,
  • Daniela Mancuso and
  • Luisa Cavalletto
  • + 2 authors+ 0 author

Fontan-associated liver disease (FALD) is an arising clinical entity that can occur long after a successful Fontan operation for correction of single ventricle (SV) congenital heart disease (CHD). Occurrence of FALD is characterized by liver cirrhosi...

  • Article
  • Open Access
9 Citations
3,150 Views
11 Pages

Glomerular Hyperfiltration: A Marker of Fibrosis Severity in Metabolic Associated Steatotic Liver Disease in an Adult Population

  • Andrea Dalbeni,
  • Marta Garbin,
  • Mirko Zoncapè,
  • Sara Romeo and ,
  • Filippo Cattazzo,
  • Anna Mantovani,
  • Annalisa Cespiati,
  • Anna Ludovica Fracanzani,
  • Emmanouil Tsochatzis and
  • Rosa Lombardi
  • + 7 authors+ 2 authors

31 October 2023

Glomerular hyperfiltration (GH) is an increase in the glomerular filtration rate, possibly progressing to chronic kidney disease (CKD). Metabolic-associated steatotic liver disease (MASLD) is linked to an increased risk of CKD, especially if fibrosis...

(This article belongs to the Special Issue Nonalcoholic Fatty Liver Disease/Metabolic Associated Fatty Liver Disease: New Insights 3.0)
  • Article
  • Open Access
4 Citations
5,570 Views
15 Pages

Use of a Micronutrient Cocktail to Improve Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) in Adults with Obesity: A Randomized, Double-Blinded Pilot Clinical Trial

  • Iulia Teodora Perva,
  • Iulia Elena Simina,
  • Renata Bende,
  • Alexandru Cătălin Motofelea and ,
  • Adela Chirita Emandi,
  • Nicoleta Andreescu,
  • Alexandra Sima,
  • Adrian Vlad,
  • Ioan Sporea and
  • Mihai Dinu Niculescu
  • + 8 authors+ 3 authors

21 August 2024

Background and Objectives: The goal of this study was to assess the impact of supplementation with a combination of nutrients on metabolic-dysfunction-associated steatotic liver disease (MASLD)-related liver parameters, and other parameters related t...

(This article belongs to the Special Issue An Update to the Epidemiology, Diagnostic Challenges, and Molecular Bases of Nonalcoholic Fatty Liver Disease)
  • Article
  • Open Access
3 Citations
2,917 Views
12 Pages

Fibrosis Progression in Patients with Budd–Chiari Syndrome and Transjugular Intrahepatic Portosystemic Shunt (TIPS): A Long-Term Study Using Transient Elastography

  • Martin Rössle,
  • Dominik Bettinger,
  • Lukas Sturm,
  • Marlene Reincke and ,
  • Robert Thimme and
  • Michael Schultheiss
  • + 1 author+ 0 author

Hepatic vein outflow obstruction causes congestion of the liver, leading to necrosis, fibrosis, and portal hypertension (PH). A transjugular intrahepatic portosystemic shunt (TIPS) reduces congestion and PH by providing artificial outflow. The aim of...

(This article belongs to the Special Issue Diagnosis and Management of Liver Diseases—2nd Edition)
  • Article
  • Open Access
2 Citations
1,204 Views
17 Pages

Abdominal Obesity, Hepatic Steatosis, Oxidative Stress and Diastolic Dysfunction in Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease

  • Luca Colangeli,
  • Ilaria Milani,
  • Maria Eugenia Parrotta,
  • Susanna Longo and ,
  • Alessandro Nucera,
  • Massimo Federici,
  • Simonetta Palleschi,
  • Barbara Rossi,
  • Alessandro Mantovani and
  • Valeria Guglielmi
  • + 9 authors+ 4 authors

18 February 2026

Metabolic dysfunction-associated steatotic liver disease (MASLD) is increasingly recognized as a key contributor to the development of heart failure with preserved ejection fraction in individuals with obesity. This study aimed to investigate whether...

(This article belongs to the Special Issue Advances in Obesity Research: Metabolic Pathways and Pathophysiological Factors)
  • Article
  • Open Access
12 Citations
4,338 Views
16 Pages

Assessing Non-Invasive Liver Function in Patients with Intestinal Failure Receiving Total Parenteral Nutrition—Results from the Prospective PNLiver Trial

  • Elisabeth Blüthner,
  • Ulrich-Frank Pape,
  • Martin Stockmann,
  • Mirjam Karber and ,
  • Sebastian Maasberg,
  • Sophie Pevny,
  • Undine Gerlach-Runge,
  • Andreas Pascher,
  • Johann Pratschke and
  • Jan Bednarsch
  • + 6 authors+ 1 author

26 April 2020

Liver abnormalities in intestinal failure (IF) patients receiving parenteral nutrition (PN) can progress undetected by standard laboratory tests to intestinal failure associated liver disease (IFALD). The aim of this longitudinal study is to evaluate...

(This article belongs to the Special Issue Contemporary Issues in Nutrition Research)
  • Article
  • Open Access
2,872 Views
14 Pages

Prevalence of Liver Steatosis and Fibrosis Assessed by Transient Elastography in a High Cardiovascular-Risk Outpatient Cohort Including T1DM and T2DM Patients

  • Alina N. Saidi,
  • Willy B. Theel,
  • Diederick E. Grobbee,
  • Aart-Jan van der Lely and ,
  • Femme Dirksmeier-Harinck,
  • Marco Alings,
  • Ellen van der Zwan-van Beek,
  • Simone P. Rauh,
  • Moniba Rasheed and
  • Manuel Castro Cabezas
  • + 5 authors+ 0 author

Background: Metabolic dysfunction-associated steatotic liver disease (MASLD) is common in T2DM, likely due to insulin resistance and obesity. Although screening is recommended in high-risk patients, its prevalence in outpatient cardiovascular clinica...

  • Article
  • Open Access
3 Citations
1,626 Views
14 Pages

Multiparametric Quantitative Ultrasound as a Potential Imaging Biomarker for Noninvasive Detection of Nonalcoholic Steatohepatitis: A Clinical Feasibility Study

  • Trina Chattopadhyay,
  • Hsien-Jung Chan,
  • Duy Chi Le,
  • Chiao-Yin Wang and ,
  • Dar-In Tai,
  • Zhuhuang Zhou and
  • Po-Hsiang Tsui
  • + 2 authors+ 0 author

1 September 2025

Objectives: The FibroScan–aspartate transaminase (AST) score (FAST score) is a hybrid biomarker combining ultrasound and blood test data for identifying nonalcoholic steatohepatitis (NASH). This study aimed to assess the feasibility of using qu...

(This article belongs to the Section Medical Imaging and Theranostics)
  • Article
  • Open Access
33 Citations
8,757 Views
11 Pages

Gender Differences in Liver Steatosis and Fibrosis in Overweight and Obese Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease before and after 8 Weeks of Very Low-Calorie Ketogenic Diet

  • Roberta Rinaldi,
  • Sara De Nucci,
  • Rossella Donghia,
  • Rosanna Donvito and ,
  • Nicole Cerabino,
  • Martina Di Chito,
  • Alice Penza,
  • Francesco Pio Mongelli,
  • Endrit Shahini and
  • Giovanni De Pergola
  • + 11 authors+ 6 authors

8 May 2024

Obesity and metabolic syndrome are linked to steatotic liver disease (SLD), the most common form of chronic liver disease. Lifestyle modifications and dieting are strategies that can prevent metabolic dysfunction-associated steatotic liver disease (M...

(This article belongs to the Section Nutrition and Obesity)
  • Article
  • Open Access
61 Views
10 Pages

Increased Liver Stiffness in Systemic Sclerosis: A Single-Centre Transient Elastography Study

  • Nicola Ortalli,
  • Alberto Civolani,
  • Simone Aldo Lari,
  • Emanuela Vargiu and ,
  • Erika Meleddu,
  • Maria Maddalena Angioni,
  • Alberto Floris,
  • Sara Onali,
  • Matteo Piga and
  • Alberto Cauli
  • + 7 authors+ 2 authors

4 November 2026

Background/Objectives: This study aimed to evaluate whether liver stiffness (LS), as assessed by transient elastography (TE), is increased in patients with systemic sclerosis (SSc) and to identify the factors associated with LS. Methods: In this expl...

(This article belongs to the Section Immunology & Rheumatology)
  • Article
  • Open Access
9 Citations
8,584 Views
14 Pages

Beyond Weight Loss: Comparative Effects of Tirzepatide Plus Low-Energy Ketogenic Versus Low-Calorie Diet on Hepatic Steatosis and Stiffness in MASLD

  • Luigi Schiavo,
  • Biagio Santella,
  • Monica Mingo,
  • Gianluca Rossetti and ,
  • Marcello Orio and
  • Vincenzo Pilone
  • + 1 author+ 0 author

24 July 2025

Background: Metabolic dysfunction-associated steatotic liver disease (MASLD) is the most common chronic liver condition globally, strongly linked to obesity, insulin resistance, and type 2 diabetes (T2D). Tirzepatide (TZP), a dual GIP/GLP-1 receptor...

(This article belongs to the Special Issue Advances in Nutrition for Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) Management: Current Perspectives from the Bench to the Bedside)
  • Article
  • Open Access
1 Citations
919 Views
27 Pages

9 July 2026

Background/Objectives: The aim of this study is to evaluate the relationship between adherence to the Mediterranean diet and intestinal microbiota metabolite trimethylamine N-oxide (TMAO) levels, systemic inflammation markers, and oxidative stress pa...

(This article belongs to the Section Nutrition and Metabolism)
  • Article
  • Open Access
49 Citations
5,308 Views
14 Pages

Screening for Liver Fibrosis and Steatosis in a Large Cohort of Patients with Type 2 Diabetes Using Vibration Controlled Transient Elastography and Controlled Attenuation Parameter in a Single-Center Real-Life Experience

  • Ioan Sporea,
  • Ruxandra Mare,
  • Alina Popescu,
  • Silviu Nistorescu and ,
  • Victor Baldea,
  • Roxana Sirli,
  • Adina Braha,
  • Alexandra Sima,
  • Romulus Timar and
  • Raluca Lupusoru
  • + 5 authors+ 0 author

6 April 2020

Background: Type 2 diabetes mellitus (T2DM), obesity, hyperlipidemia, and hypertension are considered risk factors for developing non-alcoholic fatty liver disease (NAFLD). This study aims to assess steatosis and fibrosis severity in a cohort of T2DM...

(This article belongs to the Special Issue Pathophysiology and Complications of Type 2 Diabetes Mellitus)
  • Systematic Review
  • Open Access
50 Citations
6,208 Views
10 Pages

8 January 2022

An association between liver stiffness, a surrogate measure of liver fibrosis, and chronic kidney disease (CKD) in patients with nonalcoholic fatty liver disease (NAFLD) has been proposed. However, most studies were small and had low statistical powe...

(This article belongs to the Section Lipids)
  • Review
  • Open Access
19 Citations
7,324 Views
24 Pages

A New Endemic of Concomitant Nonalcoholic Fatty Liver Disease and Chronic Hepatitis B

  • Hira Hanif,
  • Muzammil M. Khan,
  • Mukarram J. Ali,
  • Pir A. Shah and ,
  • Jinendra Satiya,
  • Daryl T.Y. Lau and
  • Aysha Aslam
  • + 2 authors+ 0 author

Hepatitis B virus (HBV) infection remains a global public problem despite the availability of an effective vaccine. In the past decades, nonalcoholic fatty liver disease (NAFLD) has surpassed HBV as the most common cause of chronic liver disease worl...

(This article belongs to the Special Issue Updates on HBV Infection)
  • Article
  • Open Access
15 Citations
5,190 Views
11 Pages

Higher-Level Steatosis Is Associated with a Greater Decrease in Metabolic Dysfunction-Associated Steatoic Liver Disease after Eight Weeks of a Very Low-Calorie Ketogenic Diet (VLCKD) in Subjects Affected by Overweight and Obesity

  • Annamaria Sila,
  • Sara De Nucci,
  • Caterina Bonfiglio,
  • Vincenza Di Stasi and ,
  • Nicole Cerabino,
  • Martina Di Chito,
  • Roberta Rinaldi,
  • Paola Cantalice,
  • Endrit Shahini and
  • Giovanni De Pergola
  • + 12 authors+ 7 authors

18 March 2024

The most common form of chronic liver disease, recently defined as MASLD, is strongly linked to obesity and metabolic syndrome. Lifestyle changes are part of MASLD prevention. The very low-calorie ketogenic diet (VLCKD) is a useful option for treatin...

(This article belongs to the Special Issue Dietary Patterns and Clinical Health Outcomes)
  • Article
  • Open Access
8 Citations
4,270 Views
14 Pages

Relationships of Dietary Habits and Physical Activity Status with Non-Alcoholic Fatty Liver Disease Featuring Advanced Fibrosis

  • Yoshito Yabe,
  • Taeho Kim,
  • Sechang Oh,
  • Takashi Shida and ,
  • Natsumi Oshida,
  • Naoyuki Hasegawa,
  • Kosuke Okada,
  • Noriko Someya,
  • Yuji Mizokami and
  • Junichi Shoda
  • + 5 authors+ 0 author

(1) Aim: Hepatic fibrosis is a prognostic factor for disease progression in non-alcoholic fatty liver disease (NAFLD). We aimed to determine the relationships between diet, physical activity, and the progression of liver fibrosis. (2) Methods: The 34...

  • Article
  • Open Access
7 Citations
3,119 Views
9 Pages

Dynamic Changes in Liver Stiffness in Patients with Chronic Hepatitis B Undergoing Antiviral Therapy

  • Alin Lazar,
  • Ioan Sporea,
  • Alexandru Popa,
  • Raluca Lupusoru and ,
  • Diana Gherhardt,
  • Ruxandra Mare,
  • Alexandru Apostu,
  • Madalina Hnatiuc and
  • Roxana Șirli
  • + 4 authors+ 0 author

31 October 2022

This is a retrospective single-center study that included 87 subjects. All subjects had chronic hepatitis B or HBV cirrhosis and underwent nucleos(t)ide analogs (NUC) treatment for more than one year. The study aimed to evaluate the dynamic changes i...

(This article belongs to the Special Issue Recent Advances of Ultrasound Elastography in Diagnostics and Therapeutics)
  • Article
  • Open Access
13 Citations
4,888 Views
9 Pages

Increased Circulating VAP-1 Levels Are Associated with Liver Fibrosis in Chronic Hepatitis C Infection

  • Marcel Kraemer,
  • Marcin Krawczyk,
  • Fozia Noor,
  • Frank Grünhage and ,
  • Frank Lammert and
  • Jochen G. Schneider
  • + 1 author+ 0 author

17 January 2019

Vascular adhesion protein-1 (VAP-1) is a multifunction protein. While membrane-bound VAP-1 is an adhesion protein, soluble VAP-1 catalyzes the deamination of primary amines through its semicarbazide-sensitive amino oxidase (SSAO) activity. VAP-1 supp...

(This article belongs to the Section Gastroenterology & Hepatopancreatobiliary Medicine)
  • Article
  • Open Access
12 Citations
5,827 Views
13 Pages

Liver Involvement in Patients with Systemic Sclerosis: Role of Transient Elastography in the Assessment of Hepatic Fibrosis and Steatosis

  • Giovanna Cuomo,
  • Carlo Iandoli,
  • Raffaele Galiero,
  • Alfredo Caturano and ,
  • Claudio Di Vico,
  • Danilo Perretta,
  • Pier Vincenzo Adamo,
  • Roberta Ferrara,
  • Luca Rinaldi and
  • Ferdinando Carlo Sasso
  • + 6 authors+ 1 author

Background Systemic sclerosis (SSc) is a rare, multisystemic disorder of connective tissue characterized by widespread inflammation, vascular abnormalities, and both skin and visceral organ fibrosis. Tissue fibrosis is the final phase of a complex bi...

(This article belongs to the Special Issue Advances in Identification and Management of Systemic Sclerosis)
  • Article
  • Open Access
4 Citations
4,371 Views
14 Pages

21 February 2025

Background and Aims: Primary biliary cholangitis (PBC) leads to the slow, progressive destruction of the small bile ducts with consecutive cholestasis and intrahepatic cholangitis. If this disease remains untreated, liver parenchyma will be damaged r...

(This article belongs to the Section Personalized Therapy and Drug Delivery)
  • Article
  • Open Access
1,951 Views
11 Pages

15 December 2025

Background: Methotrexate (MTX), a widely used therapeutic agent, is associated with hepatotoxicity. While cumulative MTX dosage has historically been linked to liver injury, recent evidence highlights the potential role of metabolic syndrome (MetS) a...

  • Systematic Review
  • Open Access
20 Citations
7,469 Views
40 Pages

Comparing FIB-4, VCTE, pSWE, 2D-SWE, and MRE Thresholds and Diagnostic Accuracies for Detecting Hepatic Fibrosis in Patients with MASLD: A Systematic Review and Meta-Analysis

  • Mitchell Patrick Wilson,
  • Ranjit Singh,
  • Shyam Mehta,
  • Mohammad Hassan Murad and ,
  • Christopher Fung and
  • Gavin Low
  • + 1 author+ 0 author

Objectives: To compare thresholds and accuracies of FIB-4, vibration-controlled transient elastography (VCTE), point shear wave elastography (pSWE), 2D shear wave elastography (2D-SWE), and MR elastography (MRE) for detecting hepatic fibrosis in pati...

(This article belongs to the Special Issue Diagnostic Imaging in Gastrointestinal and Liver Diseases)
  • Article
  • Open Access
2 Citations
1,800 Views
11 Pages

Readily Available Index of Insulin Sensitivity Is Associated with Metabolic Dysfunction-Associated Steatotic Liver Disease and Liver Fibrosis in Patients with Type 2 Diabetes

  • Stefano Ciardullo,
  • Alessandro Roberto Dodesini,
  • Emanuele Muraca,
  • Pietro Invernizzi and ,
  • Roberto Trevisan and
  • Gianluca Perseghin
  • + 1 author+ 0 author

Background/Objectives: Insulin resistance is a key factor in the development and progression of metabolic dysfunction-associated steatotic liver disease (MASLD), but accurately measuring it in patients with type 2 diabetes (T2D) remains challenging....

  • Article
  • Open Access
2,326 Views
27 Pages

Innovative Elastography Measuring Cap for Ex Vivo Liver Condition Assessment: Numerical and Preclinical Studies in a Porcine Model

  • Dariusz Pyka,
  • Agnieszka Noszczyk-Nowak,
  • Karina Krawiec,
  • Tomasz Świetlik and
  • Krzysztof J. Opieliński

16 January 2025

The authors of this study focused their research on developing cap geometries for the FibroScan® elastograph (FibroScan, EchoSens, Paris, France) measuring head aimed at a non-invasive assessment of liver condition for transplantation using a pig...

(This article belongs to the Special Issue Liver Fibrosis: Mechanisms, Targets, Assessment and Treatment)
  • Article
  • Open Access
3 Citations
2,209 Views
17 Pages

15 October 2025

Background and Objectives: Metabolic dysfunction-associated steatotic liver disease (MASLD) is closely linked with type 2 diabetes mellitus (T2D) and obesity. Despite its growing prevalence, effective pharmacological interventions remain limited, wit...

(This article belongs to the Section Endocrinology)

of 4